Anthony Montag Selected Research

MAP Kinase Kinase 4

6/2012	Time-dependent transcriptional profiling links gene expression to mitogen-activated protein kinase kinase 4 (MKK4)-mediated suppression of omental metastatic colonization.
11/2002	Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anthony Montag Research Topics

Disease

15	Neoplasms (Cancer) 01/2019 - 01/2002
9	Neoplasm Metastasis (Metastasis) 01/2019 - 05/2002
8	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 11/2002
3	Endometrial Neoplasms (Endometrial Cancer) 01/2015 - 03/2009
2	Adenocarcinoma 01/2015 - 06/2011
2	Carcinogenesis 06/2011 - 02/2008
2	Carcinoma (Carcinomatosis) 04/2011 - 11/2002
2	Osteosarcoma (Osteogenic Sarcoma) 02/2008 - 05/2002
1	Testicular Neoplasms (Testicular Cancer) 01/2018
1	Endometrial Hyperplasia 01/2015
1	Hyperplasia 01/2015
1	Endometrioid Carcinoma 01/2015
1	Wounds and Injuries (Trauma) 01/2014
1	Gonadoblastoma 09/2011
1	Dysgerminoma 09/2011
1	Breast Neoplasms (Breast Cancer) 12/2010
1	Peripheral Nervous System Diseases (PNS Diseases) 12/2010
1	Myalgia 03/2009
1	Ascites 04/2008
1	Granuloma 02/2006
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2005
1	Lymphoma (Lymphomas) 09/2004
1	T-Cell Lymphoma (Lymphoma, T Cell) 09/2004
1	Leiomyosarcoma 01/2003
1	Sarcoma (Soft Tissue Sarcoma) 01/2003
1	Prostatic Neoplasms (Prostate Cancer) 01/2002

Drug/Important Bio-Agent (IBA)

3	IntegrinsIBA 10/2014 - 02/2008
2	Small Interfering RNA (siRNA)IBA 01/2019 - 10/2014
2	AntigensIBA 01/2018 - 01/2002
2	ParaffinIBA 01/2018 - 09/2011
2	MAP Kinase Kinase 4IBA 06/2012 - 11/2002
2	Transcription Factors (Transcription Factor)IBA 09/2011 - 12/2010
2	Cisplatin (Platino)FDA LinkGeneric 12/2010 - 03/2009
2	Cadherins (E-Cadherin)IBA 12/2010 - 04/2008
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2010 - 03/2009
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2010 - 03/2009
2	Proteins (Proteins, Gene)FDA Link 04/2008 - 09/2004
1	fascinIBA 01/2019
1	Amino Acids FDA Link 01/2019
1	EnzymesIBA 01/2019
1	GlycogenIBA 01/2019
1	IsotopesIBA 01/2019
1	PhosphoglucomutaseIBA 01/2019
1	Glycogen Phosphorylase (Phosphorylase, Glycogen)IBA 01/2019
1	Formaldehyde (Formol)FDA Link 01/2018
1	Biological ProductsIBA 01/2018
1	ProteomeIBA 01/2018
1	PlatinumIBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	Progesterone FDA LinkGeneric 01/2015
1	Estrogens (Estrogen)FDA Link 01/2015
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	Fibronectins (Fibronectin)IBA 10/2014
1	AntibodiesIBA 10/2014
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 06/2011
1	GSK 1363089IBA 06/2011
1	Indicators and Reagents (Reagents)IBA 06/2011
1	Proto-Oncogene Proteins c-metIBA 04/2011
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 04/2011
1	Urokinase Plasminogen Activator ReceptorsIBA 02/2011
1	ATN-658IBA 02/2011
1	Caspase 3 (Caspase-3)IBA 02/2011
1	adhesion receptorIBA 04/2008
1	Immunoglobulin G (IgG)IBA 04/2008
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 02/2008
1	thrombin receptor peptide SFLLRNPIBA 02/2008
1	Peptide Hydrolases (Proteases)FDA Link 02/2008
1	Thrombin FDA Link 02/2008
1	Serine Proteases (Serine Protease)IBA 02/2008
1	Thrombin Receptors (Thrombin Receptor)IBA 02/2008
1	CarrageenanIBA 02/2006
1	nickel copper alloyIBA 06/2005
1	CarcinogensIBA 09/2004
1	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 09/2004
1	DNA (Deoxyribonucleic Acid)IBA 09/2004
1	AntimetabolitesIBA 01/2003
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 11/2002
1	StathminIBA 11/2002
1	LigandsIBA 05/2002
1	PPAR-gamma AgonistsIBA 05/2002
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 05/2002
1	Methylnitronitrosoguanidine (MNNG)IBA 05/2002
1	Troglitazone (Rezulin)FDA Link 05/2002
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 05/2002
1	Retinoid X Receptors (Retinoid X Receptor)IBA 05/2002
1	PPAR gammaIBA 05/2002
1	ciglitazoneIBA 05/2002
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2002
1	VaccinesIBA 01/2002
1	Keratins (Keratin)IBA 01/2002

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2018 - 11/2002
5	Therapeutics 06/2011 - 05/2002
2	Immunotherapy 01/2018 - 01/2002
1	Catheters 01/2014
1	Radiofrequency Ablation 01/2014
1	Protective Devices (Safety Device) 01/2014
1	Subcutaneous Injections 02/2006
1	Radiotherapy 01/2003